In the cases with TLS, the number of infiltrating CD8+ T cells, CD4+ T cells, CD20+ B cells, or CD38+ plasma cells (plasma cell score) was significantly higher than in those without TLS (P < 0.0001, each) (Figure 1C). The gene discussed is CD38; the disease is Tumor Lysis Syndrome.